openPR Logo
Press release

Drug discovery informatics market t Exhibit a Remarkable CAGR 11.77% Size, Share, Trends, Key Drivers, Demand, Opportunity Analysis and Competitive Outlook

Drug discovery informatics market t Exhibit a Remarkable CAGR

Drug discovery informatics market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses the market to account to USD 5.42 billion by 2028 and will grow at a CAGR of 11.77% in the above mentioned forecast period.

Market Overview

This drug discovery informatics market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on drug discovery informatics market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Explore Further Details about This Research Drug Discovery Informatics Market Report https://www.databridgemarketresearch.com/reports/global-drug-discovery-informatics-market

Global Drug Discovery Informatics Market Scope and Market Size

Drug discovery informatics market is segmented on the basis of function, solutions, workflow, mode and end user. The growth amongst these segments will help you analyze meager growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

Based on function, the drug discovery informatics market is segmented into sequencing and target data analysis, docking, molecular modeling, library and database preparation and others. Others have further been segmented into screening and ADMET characterization.
On the basis of solutions, the drug discovery informatics market is segmented into software and services.
On the basis of workflow, the drug discovery informatics market is segmented into drug discovery and drug development. Drug discovery has further been segmented into identification and validation informatics assay development informatics and lead generation information processing. Drug development has further been segmented into lead optimization, FHD preparation, phase IA and phase IB/2.
Based on mode, the drug discovery informatics market is segmented into in-house informatics and outsourced informatics.
The end user segment of drug discovery informatics market is segmented into pharmaceutical and biotechnology companies, contract research organizations (CROS) and others.

 Drug Discovery Informatics Market Country Level Analysis

Drug discovery informatics market is analyzed and market size insights and trends are provided by country, function, solutions, workflow, mode and end user as referenced above.

The countries covered in the drug discovery informatics market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa(MEA), Brazil, Argentina and Rest of South America as part of South America.

North America region leads the drug discovery informatics market owing to the high incidence rates of different infectious diseases and oncology diseases as well as high growth of next generation sequencing and chemical laboratories within the region. Asia-Pacific is expected to expand at a significant growth rate over the forecast period of 2021 to 2028 because of the presence of drug nanotechnology sector and ongoing research in software within this particular region.

The country section of the drug discovery informatics market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

The major players covered in the drug discovery informatics market report are Jubilant Biosys, IBM, Infosys Limited, Eurofins Scientific, Thermo Fisher Scientific, PerkinElmer Inc., Schrödinger, Inc., Dassault Systèmes,  Charles River Laboratories, Selvita, Certara, GVK Biosciences Private Limited, Collaborative Drug Discovery, Inc, OpenEye Scientific Software, IO Informatics, Inc., Albany Molecular Research Inc.,  Cognizant, Insilico Medicine and Boehringer Ingelheim International GmbH among other domestic and global players. Market share data is available for Global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

Key Offerings:

Past Market Size and Competitive Landscape (2018 to 2022)
Past Pricing and price curve by region (2018 to 2022)
Market Size, Share, Size & Forecast by different segment | 2023-2029
Market Dynamics - Growth Drivers, Restraints, Opportunities, and Key Trends by Region
Market Segmentation - A detailed analysis by segment with their sub-segments and Region
Competitive Landscape - Profiles of selected key players by region from a strategic perspective
Competitive landscape - Drug Discovery Informatics Market Leaders, Market Followers, Regional player
Competitive benchmarking of key players by region
PESTLE Analysis
PORTER's analysis
Value chain and supply chain analysis
Legal Aspects of Business by Region
Lucrative business opportunities with SWOT analysis
Recommendations

Browse Related Reports:

https://dbmrnews456.blogspot.com/2024/03/the-drug-discovery-informatics-market.htmlhttps://dbmrnews456.blogspot.com/2024/03/digital-pills-market-forecast-to-2029.htmlhttps://dbmrnews123.blogspot.com/2024/03/portable-oxygen-concentrators-market.htmlhttps://dbmrnews123.blogspot.com/2024/03/the-rehabilitation-equipment-market.html

Contact Us:-
Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
Email:- corporatesales@databridgemarketresearch.com

About Data Bridge Market Research:

An absolute way to forecast what future holds is to comprehend the trend today!

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavours to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data Bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune.

Data Bridge Market Research has over 500 analysts working in different industries. We have catered more than 40% of the fortune 500 companies globally and have a network of more than 5000+ clientele around the globe. Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. We are content with our glorious 99.9 % client satisfying rate.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Drug discovery informatics market t Exhibit a Remarkable CAGR 11.77% Size, Share, Trends, Key Drivers, Demand, Opportunity Analysis and Competitive Outlook here

News-ID: 3429960 • Views:

More Releases from Data Bridge Market Research

Feed Probiotic Yeast Market : Trends and Future Growth Analysis by 2031
Feed Probiotic Yeast Market : Trends and Future Growth Analysis by 2031
The "Feed Probiotic Yeast Market" is a dynamic and rapidly evolving sector, with significant advancements and growth anticipated by 2031. Comprehensive market research reveals a detailed analysis of market size, share, and trends, providing valuable insights into its expansion. This report delves into segmentation and definition, offering a clear understanding of market components and drivers. Employing SWOT and PESTEL analyses, the study evaluates the market's strengths, weaknesses, opportunities, and threats,
Blood Glucose Test Strip Market Insights By 2031 | Anticipating Growth and Advancements with Opportunities and Challenges
Blood Glucose Test Strip Market Insights By 2031 | Anticipating Growth and Advan …
The "Blood Glucose Test Strip Market" is a dynamic and rapidly evolving sector, with significant advancements and growth anticipated by 2031. Comprehensive market research reveals a detailed analysis of market size, share, and trends, providing valuable insights into its expansion. This report delves into segmentation and definition, offering a clear understanding of market components and drivers. Employing SWOT and PESTEL analyses, the study evaluates the market's strengths, weaknesses, opportunities, and
Fertigation and Chemigation Market Forecast: Trends and Analysis 2024-2031
Fertigation and Chemigation Market Forecast: Trends and Analysis 2024-2031
The "Feed Probiotic Yeast Market" is a dynamic and rapidly evolving sector, with significant advancements and growth anticipated by 2031. Comprehensive market research reveals a detailed analysis of market size, share, and trends, providing valuable insights into its expansion. This report delves into segmentation and definition, offering a clear understanding of market components and drivers. Employing SWOT and PESTEL analyses, the study evaluates the market's strengths, weaknesses, opportunities, and threats,
Eukaryotic Expression Systems Market Forecast 2024-2031: Trends and Analysis
Eukaryotic Expression Systems Market Forecast 2024-2031: Trends and Analysis
The "Eukaryotic Expression Systems Market" is a dynamic and rapidly evolving sector, with significant advancements and growth anticipated by 2031. Comprehensive market research reveals a detailed analysis of market size, share, and trends, providing valuable insights into its expansion. This report delves into segmentation and definition, offering a clear understanding of market components and drivers. Employing SWOT and PESTEL analyses, the study evaluates the market's strengths, weaknesses, opportunities, and threats,

All 5 Releases


More Releases for Drug

Alcohol Testing And Drug Testing Equipment Market 2025 Segmentation, Application …
Market Study Report, LLC, has compiled an exhaustive research study of the ‘Alcohol Testing And Drug Testing Equipment market’, detailing every single market driver and intricately analyzing the business vertical. This ‘Alcohol Testing And Drug Testing Equipment market’ study will aid in seeking out new business opportunities and fine-tuning existing marketing strategies through insights regarding SWOT analysis, market valuation, competitive spectrum, regional share, and revenue predictions. Alcohol abuse and drug
How much Diabetes Drug Market Impact Worldwide Medical Drug Industry?
Diabetes Drug Market From an insight perspective, the market report focuses on various levels of analyses — industry analysis, market rank analysis, and company profiles, which together comprise and discuss basic views on the competitive landscape, high-growth regions, and countries as well as their respective regulatory policies, Types ,Applications and opportunities in the market.  Diabetes is a metabolic disorder in which the body glucose level is elevated. There are two types of diabetes
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Introduction to Hepatitis Disease 1.1 Prologue 1.1.1 History of Hepatitis 1.1.2 Causes of Hepatitis Disease 1.2 Types of Viruses which are Responsible for Hepatitis Disease 2. Global Prevalence of Hepatitis Infection 3. Available Drug Classes for Hepatitis Disease Treatment 3.1 Interferon Alfa Therapy 3.2 Protease Inhibitors Therapy 3.3 Polymerase
Microcapsules Drug Delivery Market Microcapsules Drug Delivery Sales Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Indispensable Advent of Microcapsules 1.1 Trajectory of Microencapsulation 1.2 Why and wherefores for Microencapsulation 2. Characterization of Microcapsules 2.1 Composition of Microcapsules 2.2 Parameters Influencing Microcapsules 3. Engineering Technology of Microcapsules 3.1 Physical Manufacturing Technologies 3.2 Physicochemical and Chemical Technologies 4. Applicability of Microcapsules 4.1 Microcapsules in Pharmaceuticals 4.2 Microcapsules in Nutraceuticals
AstraZeneca’s NMOSD Drug receives orphan drug designation
April 18, 2017 Orphan Drug European Medicine Agency has Announced orphan drug designation for inebilizumab (earlier known as MEDI-551) developed by AstraZeneca PLC (AZN) for the treatment of neuromyelitis optica spectrum disorder (NMOSD). The drug has already received orphan drug status from US Food and Drug Administration (FDA). NMOSD, also called Devic’s disease, is a rare, autoimmune disorder of the central nervous system (CNS) that affects the functioning
Drug Discovery Strategies, PBPK Modeling and Drug-Drug Interaction Explored and …
This year’s 12th annual ADMET conference and exhibition promises to deliver appearances from experienced pharmaceutical professionals from ADME and PK/PD organisations such as AbbVie, GSK, Roche and Bayer when it returns to London this June. The carefully selected speaker line up will be addressing early ADME application strategies and discussing the latest technologically advanced screening and testing models along with exploring ADMET technologies which will identify properties of a drug